Purpose The identification of significant fibrosis is critical for predicting the prognosis of non-
alcoholic fatty liver disease (NAFLD). This study aimed to compare the predictive value of …

Background/Aims Non-alcoholic fatty liver disease (NAFLD) represents a significant public
health issue. Identifying patients with simple steatosis from those with non-alcoholic …

Aims The study aimed to develop a novel noninvasive model to detect advanced fibrosis
based on routinely available clinical and laboratory tests. Materials and Methods A total of …

Background Fibrosis is deemed to be a pivotal determinant of the long-term prognosis in
non-alcoholic fatty liver disease (NAFLD). Objective We aimed to develop a novel …

Background In nonalcoholic fatty liver disease (NAFLD), advanced fibrosis has been
identified as an important prognostic factor with increased liver-related mortality and …

BACKGROUND & AIMS: There is a need for a reliable and inexpensive noninvasive marker
of hepatic fibrosis in nonalcoholic fatty liver disease (NAFLD). The aim of this study was to …

Abstract Aim The noninvasive tests (NITs) Agile 3+ and Agile 4 effectively identify patients
with nonalcoholic fatty liver disease (NAFLD) complicated with advanced fibrosis (F3–4) and …

Background and aims. Non-alcoholic fatty liver disease (NAFLD) is a common, morbid
disease with profound implications for the overall health of the patient. We set out to …

Background The presence of significant liver fibrosis is a key determinant of long‐term
prognosis in non‐alcoholic fatty liver disease (NAFLD). We aimed to develop a novel …

Aims To develop, validate and compare a non-invasive fibrosis scoring system for non-
alcoholic fatty liver disease (NAFLD) derived from routinely obtained clinical and …